Almac opens new facility at NC-based campus following increased customer demand

By Melissa Fassbender

- Last updated on GMT

(Image: Almac Group)
(Image: Almac Group)

Related tags CDMO Almac group

Almac has opened a new 24,000 square foot building at its location in Durham, NC to meet demand driven by the rise in biological investigational products, says CDMO.

The contract pharmaceutical development and manufacturing organization (CDMO​) has completed its investment in its Durham, NC Clinical Services’ and Diagnostic Services’ capabilities.

The 24,000 square foot building is the company’s fourth at this location and provides additional office space for more than 100 new employees expected to be hired over the next three years.

“The main driver for growth globally (including NC) is the rise in biological investigational products, and data driven outcomes such as global temperature management and clinical site/patient driven innovations in the clinical supply chain,”​ Jonathan Calderwood, commercial development director, Almac Clinical Services, told us.

Almac announced ​a $5.2m investment in its US-based operations in 2016. The investment has expanded its clinical services operations as well as its diagnostics and clinical technologies services.

"Across the Almac companies there is a need to ensure that we are continually investing in staff and facilities to maintain the excellent standards that our customers have come to expect of us,"​ Donna Christopher, global VP of operations told us at the time​, adding that the company's activities in NC continue to grow, and as such, it is "seeking to meet that additional demand ."

Additionally, earlier this month, Almac’s Sciences Business Unit combined its capabilities​ with BioClin to form an analytical group spanning the UK, Europe, and North America.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more